Registration Information

Registration is now open

PRIMO ADC Summit
January 27, February 3, February 17, 2021

Registration is FREE for all Healthcare Practitioners

Objectives

Review this comprehensive program, including an on-demand webcast and downloadable slidesets to gain expert perspectives on the emerging clinical data of ADCs, and participate in discussion regarding:

  • The structure of ADCs and how they are unique in cancer therapy
  • Review of emerging clinical data with ADCs, including recent ongoing clinical trials, mechanism of action, and current and future treatment options
  • Integration of ADCs in the management of solid tumors and in treatment sequencing
  • Practical considerations for the use of ADCs, including the management of adverse events

Target Audience

This activity has been designed to meet the educational needs of Academic and Community Practitioners, as well as Registered Nurses and Advanced Practice Registered Nurses, Pharmacists and Physician Assistants involved in the care of patients with breast, lung, gastrointestinal, and colorectal cancers.

On-Demand Webcasts

Slides are available to download here.

 
1.5 Hours Total Time
Speakers
Welcome & Objectives
Welcome and Objectives
Sanjiv
0:00:00 - 0:25:00
Introduction to ADCs
Where do we stand and where are we going?

Daver
0:25:00 – 0:57:00
0:25:00 – 0:32:00
0:32:00 – 0:38:00
0:38:00 – 0:45:00
0:45:00 – 0:57:00
ADCs in Breast Cancer
FDA-Approved ADCs in Breast Cancer
ADCs Targeting HER2
T-Dxd in HER2-Low
ADCs in Triple Negative Breast Cancer

Hurvitz
Gradishar
Hurvitz
Gradishar
0:57 – 1:10:00
0:57:00 – 1:05:00
1:05:00 – 1:10:00
Treatment considerations for ADCs in Breast Cancer
Clinical Applications of ADCs
Combinations with Immunotherapy

Hurvitz
Gradishar
1:10:00 – 1:15:00
Updates from SABCS
Hurvitz
1:15:00 – 1:30:00
Live Q/A
Hurvitz + Daver

Slides are available to download here.

 
1.5 Hours Total Time
Speakers
Welcome & Objectives
Welcome and Objectives
Sanjiv
0:00:00 - 0:25:00
Introduction to ADCs
Where do we stand and where are we going?

Daver
0:25:00 – 0:45:00
ADCs in NSCLC
West, Ramalingam
0:45:00 – 0:52:00
ADCs in Gastric Cancer
Shroff
0:52:00 – 1:00:00
ADCs in CRC
Shroff
1:00:00 – 1:10:00
Clinical Applications of ADCs in NCSLC
West, Ramalingam
1:10:00 – 1:15:00
Case study of ADCs in Gastric Cancer
Shroff
1:15:00 – 1:30:00
Live Q/A
West, Ramalingam (Lung); Shroff (GI/CRC)

Slides are available to download here.

 
1.5 Hours Total Time
Speakers
Welcome & Objectives
Welcome and Objectives
Sanjiv
0:00:00 – 0:25:00
Introduction to ADCs
Where do we stand and where are we going?

Daver
0:25:00 – 1:15:00
Practical Considerations of ADC’s
Current thinking and rationale around patient selection and sequencing of ADCs in breast cancer
Evaluating the treatment landscape and data

Hurvitz + Gradishar
Hurvitz + Gradishar
Hurvitz + Gradishar
1:15:00 – 1:30:00
Live Q/A
Hurvitz + Daver

Faculty Info

Dr-Daver

Naval G. Daver, MD

Houston, TX

  • Associate Professor
    Department of Leukemia
    MD Anderson Cancer Center
Dr-Gradisher

William J. Gradishar, MD, FACP

Chicago, IL

  • Chief of Hematology and Oncology, Department of Medicine
    Betsy Bramsen Professorship of Breast Oncology
  • Professor of Medicine, Northwestern Medicine Feinberg School of Medicine
Dr-Hurvitz

Sara Hurvitz, MD

Santa Monica, CA

  • Associate Professor of Medicine
  • Director, Breast Oncology Program
    Medical Director, Clinical Research Unit
    UCLA Medical Center
Suresh Ramalingam, MD

Suresh Ramalingam, MD

Atlanta, GA

  • Professor of Hematology and Medical Oncology
    Roberto C. Goizueta Chair for Cancer Research
  • Assistant Dean for Cancer Research
  • Deputy Director, Winship Cancer Institute
    Emory University School of Medicine
Rachna T. Shroff, MD, MS

Rachna T. Shroff, MD, MS

Tucson, AZ

  • Associate Professor, Medicine - (Clinical Scholar Track)
  • Chief, Section of GI Medical Oncology, UA Cancer Center
  • Leader, GI Disease-Oriented Team, UA Cancer Center
  • Director, Clinical Trials Office
    University of Arizona Cancer Center
H. Jack West, MD

H. Jack West, MD

Seattle, WA

  • Medical Director, Thoracic Oncology Program
    Swedish Cancer Institute
  • Founder and President
    GRACE: Global Resource for Advancing Cancer Education

This activity was supported by educational grants provided by Daiichi Sankyo and Cancer Expert Now, LLC.